Addex Therapeutics (ADXN) Divestments (2023 - 2024)

Addex Therapeutics' (ADXN) quarterly Divestments came in at $5379.9 billion in Q3 2024, up 700971.86% year-on-year from N/an in Q4 2023, and up 700971.86% quarter-over-quarter from -$767.6 million in Q3 2023.

Addex Therapeutics (ADXN) Divestments (2023 - 2024) Analysis & Trends

Addex Therapeutics has disclosed Divestments across 2 years of filings, most recently posting $5379.9 billion for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Addex Therapeutics 1.23 Bn 1.23 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 5,379.89 Bn
Sep 30, 2023 -767.60 Mn